Molecular Diagnostics
Genetic Test Identifies Risk of Anal Cancer
Anal cancer is mostly caused by human papillomavirus (HPV), which is the same virus that causes cervical cancer. Diagnosis presents many challenges as full biopsies are painful, and taking a small sample of cells for cytology is problematic because lesions can be hidden. More...14 Jun 2017
Sequencing Approach to Detect Genomic Alterations
An early study evaluated a sophisticated new genomic-sequencing approach that analyzes cell-free DNA (cfDNA) in the blood of people with advanced cancer and will help development of a future assay that could potentially detect cancer in its earliest stages. More...13 Jun 2017
Genetic Mutation Identified for Childhood Kidney Cancer
The underlying mechanism that causes aneuploidy might be important in understanding cancer risk and not solely having the wrong number of chromosomes in a cell. It is an important development that provides valuable information about the fundamental biology of cancer. More...13 Jun 2017
Rapid Molecular Test Diagnoses Multiple Sclerosis
A pioneering blood test has been introduced that speeds up multiple sclerosis (MS) diagnosis to just seven days. Current testing methods such as magnetic resonance imaging scans take much longer to reach a diagnosis because they rely on measuring the progress of irreversible neurological damage. More...07 Jun 2017
Rare Infection in Transplant Recipients Linked to Donors
The way in which heart and lung transplant recipients acquired a specific species of bacteria, Mycoplasma hominis, had been previously undefined, and the bacterium was difficult to test for and detect. Originally, this bacterium was considered to reside exclusively in, and be a potential pathogen of the area of the reproductive and urinary organs. More...01 Jun 2017
Biomarkers Revealed for Cognitive Impairment in PD
Biomarkers have been identified that could predict the cognitive impairment typical of Parkinson's Disease (PD), a neurodegenerative disease that affects about half a million people in the USA, with approximately 50,000 people receive a PD diagnosis every year. More...31 May 2017
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
.jpg)
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
In Other News
Untethered Proteins Could Help Diagnose MKD
Haptoglobin Genotyping Test Enables Key Diabetes Treatment
Recurrent Mutation Linked to Childhood Blindness
Blood Sample Storage Evaluated for PEA Analysis
Metabolic Approach Helps Determine Risk of AD
Alzheimer’s Disease Progression Predicted by Gene Mutation
Pathogens Help Diagnose Fatty Liver Disease
Gene Sequencing Reveals Mutations in Endometriosis
Molecular Test Predicts Blood Cancer Patient Survival
Solvent Interaction Analysis of PSA Reduces Need for Biopsies
Elevated Levels of Beta-2 Microglobulin Linked to Increased Stroke Risk
Low Levels of Protein Linked to Cognitive Decline
Test Predicts Benefit of Targeted Cancer Treatments
Genomic Duplication Responsible for Rare Skin Disease
Typhoid Fever Victims Present Unique Metabolomic Profile
Child Biomarkers Linked to BD Parents
Immune Response Differentiates Malaria from Other Infections
POC Test Advances Hepatitis C Diagnosis
Genes Should Be Screened for Stem Cell Transplants
Genetics Are Key to Lowering Bone Fracture Risk
Novel Fluorescent Technique Detects Early Stage Glaucoma
Low Levels of 1-Asparaginase Predict Cancer Recurrence
Multigene Test Extends Life Expectancy for Cancer Patients
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.